Recruiting studies: Tardive Dyskinesia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024 Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
Phase 1/Phase 2 · 1 location(s) · Luye Pharma Group Ltd. · NCT06731868 Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Phase 4 · 1 location(s) · University Hospitals Cleveland Medical Center · NCT06997198 Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Phase 2 · 18 location(s) · Neurocrine Biosciences · NCT07365462 Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localizat
NA · 1 location(s) · Peking University Sixth Hospital · NCT07173920 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · 22 location(s) · Neurocrine Biosciences · NCT07105111

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.